Heikki Lanckriet founded Expedeon Ltd. and Expedeon Holdings Ltd. Currently, Dr. Lanckriet holds the position of CEO, Executive Director & Chief Scientific Officer at 4basebio Plc and Chief Executive Officer & Chief Scientific Officer at Expedeon Ltd.
He is also on the board of Biofrontera AG, Expedeon Holdings Ltd. (former Chief Executive Officer & Director), Kither Biotech Srl and 4basebio UK Ltd.
In his past career Heikki Lanckriet occupied the position of Chief Executive Officer & Chief Scientific Officer at 2invest AG, Principal at Puratos NV and Principal at the University of Cambridge.
He received an undergraduate degree and a graduate degree from Ghent University and a doctorate from the University of Cambridge.